[能否从初次活检预测前列腺癌的激素抵抗性？]
[Can the hormone-resistance of cancer of the prostate be predicted from the initial biopsy?].
作者信息
Bittard H, Carbillet J P, Jeldi A, Khenifar E, Shikfa M, Wenzel H, Bretillot F, Bittard M
机构信息
Service d'Urologie, CHU Besançon.
出版信息
Ann Urol (Paris). 1990;24(4):340-4.
PMID:1699470
Abstract
We present 271 prostatic adenocarcinomas with a follow-up of between 11.5 and 18 years, treated by palliative hormone therapy. Multivariate analysis defines three groups. Group 1 (78 cases): with a normal survival; Groups II and III: with poor survival. In this group, treatment is ineffective.
摘要
我们呈现了271例接受姑息性激素治疗的前列腺腺癌患者，随访时间为11.5至18年。多变量分析确定了三组。第一组（78例）：生存正常；第二组和第三组：生存较差。在这组中，治疗无效。
Zotero 插件